Robert M. Davis serves as the Chairman, Chief Executive Officer, and President of Merck & Co., Inc., a leading global biopharmaceutical company. Davis joined Merck in 2014 as the Chief Financial Officer (CFO), bringing with him a wealth of experience from his previous roles in the healthcare industry. Before joining Merck, he spent nearly two decades at Baxter International Inc., where he held various leadership positions, including CFO and President of Medical Products. His extensive financial and operational expertise has been instrumental in guiding Merck's strategic direction and growth. Under Davis's leadership, Merck has continued to focus on advancing its mission to save and improve lives through innovative medicines and vaccines. One of his notable achievements has been the successful navigation of the company through the challenges posed by the global COVID-19 pandemic, during which Merck played a crucial role in developing and distributing vital healthcare solutions. Davis has been a strong advocate for Merck's commitment to research and development, emphasizing the importance of investing in scientific innovation to address unmet medical needs worldwide. As Chairman, CEO, and President, Robert M. Davis plays a pivotal role in shaping Merck's corporate strategy and culture. He is responsible for overseeing the company's global operations, ensuring that Merck remains at the forefront of the biopharmaceutical industry. Davis's leadership style emphasizes collaboration, integrity, and a focus on long-term value creation for patients, employees, and shareholders alike. His vision for Merck is to continue expanding its portfolio of groundbreaking therapies and to maintain its position as a leader in global health.